A machine learning tool can help with diagnosing, monitoring colorectal cancer

Updated on: June 18,2025

A machine learning tool can help with diagnosing, monitoring colorectal cancer

Updated on:June 18,2025

Killer T cells get better with age, study finds

by Claudia Ehrlich, Universität des SaarlandesDr. Annette Lis (R) and Dorina Zöphel (L) of Saarland University are studying how the activity of killer cells changes as the cells age. Credit: Oliver Di

Updated on: January 23,2024

Killer T cells get better with age, study finds

by Claudia Ehrlich, Universität des SaarlandesDr. Annette Lis (R) and Dorina Zöphel (L) of Saarland University are studying how the activity of killer cells changes as the cells age. Credit: Oliver Di

Updated on:January 23,2024

Results of trial will help guide treatment of malignant bowel obstruction in patients with advanced cancer

by SWOG Cancer Research NetworkCredit: CC0 Public DomainFindings from the first-ever prospective trial including a randomized pathway comparing surgery to non-surgical treatment of malignant bowel obs

Updated on: January 04,2024

Results of trial will help guide treatment of malignant bowel obstruction in patients with advanced cancer

by SWOG Cancer Research NetworkCredit: CC0 Public DomainFindings from the first-ever prospective trial including a randomized pathway comparing surgery to non-surgical treatment of malignant bowel obs

Updated on:January 04,2024

Negative fecal tests tied to low risk for advanced colorectal cancer

by Lori SolomonThere was a low risk for advanced neoplasia after multiple rounds of negative fecal immunochemical tests (FIT) in people undergoing surveillance colonoscopy, according to a study publis

Updated on: June 22,2024

Negative fecal tests tied to low risk for advanced colorectal cancer

by Lori SolomonThere was a low risk for advanced neoplasia after multiple rounds of negative fecal immunochemical tests (FIT) in people undergoing surveillance colonoscopy, according to a study publis

Updated on:June 22,2024

Clinical trial shows durvalumab plus ceralasertib boosted immune response in lung cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung

Updated on: May 09,2024

Clinical trial shows durvalumab plus ceralasertib boosted immune response in lung cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung

Updated on:May 09,2024

Breast density notification laws not effective for all women

byYale UniversityA new study suggests that state-mandated notifications on mammogram reports intended to inform women of the health risks related to breast density are not worded effectively.The

Updated on: December 20,2023

Breast density notification laws not effective for all women

byYale UniversityA new study suggests that state-mandated notifications on mammogram reports intended to inform women of the health risks related to breast density are not worded effectively.The

Updated on:December 20,2023

The AI Blind Spot in Oncology: Why Oral Cancer Remains a Diagnostic Challenge

Oral cancer continues to exact a growing toll on global health, with incidence rates rising from 3.26 per 100,000 in 1990 to 5.34 in 2021.

Updated on: August 25,2025

The AI Blind Spot in Oncology: Why Oral Cancer Remains a Diagnostic Challenge

Oral cancer continues to exact a growing toll on global health, with incidence rates rising from 3.26 per 100,000 in 1990 to 5.34 in 2021.

Updated on:August 25,2025

Study reveals gene 'switched off' in early stages of pancreatic cancer allows rapid tumor growth and spread

byNottingham Trent UniversityHNF4A is methylated and suppressed in pancreatic cancer. Credit:Gastro Hep Advances(2024). DOI: 10.1016/j.gastha.2024.04.005Scientists at Nottingham Tren

Updated on: July 17,2024

Study reveals gene 'switched off' in early stages of pancreatic cancer allows rapid tumor growth and spread

byNottingham Trent UniversityHNF4A is methylated and suppressed in pancreatic cancer. Credit:Gastro Hep Advances(2024). DOI: 10.1016/j.gastha.2024.04.005Scientists at Nottingham Tren

Updated on:July 17,2024

Discovery could lead to better treatment for leukemia

by University of Illinois at ChicagoBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaPrevious research has revealed that patients with acute my

Updated on: April 14,2024

Discovery could lead to better treatment for leukemia

by University of Illinois at ChicagoBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaPrevious research has revealed that patients with acute my

Updated on:April 14,2024

Prostate cancer: Family history, genetics and your risk

by Jessica Saenz,Mayo ClinicCredit: Kampus Production from PexelsIf you've been diagnosed with prostate cancer, exploring what may have contributed to your cancer might not be at the top of

Updated on: November 10,2024

Prostate cancer: Family history, genetics and your risk

by Jessica Saenz,Mayo ClinicCredit: Kampus Production from PexelsIf you've been diagnosed with prostate cancer, exploring what may have contributed to your cancer might not be at the top of

Updated on:November 10,2024

Discovery could lead to 'kinder' treatment for childhood neuroblastoma

by University of CambridgeA ball of neuroblastoma cells forming mature nerves after drug treatment. Credit: Kirsty Ferguson/Developmental CellChildren with neuroblastoma—responsible for 15% of ca

Updated on: March 23,2024

Discovery could lead to 'kinder' treatment for childhood neuroblastoma

by University of CambridgeA ball of neuroblastoma cells forming mature nerves after drug treatment. Credit: Kirsty Ferguson/Developmental CellChildren with neuroblastoma—responsible for 15% of ca

Updated on:March 23,2024

A predictive biomarker of response to therapy in patients with microsatellite stable metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyA total of 166 patients with mCRCBRAF-V600Ewere included in the study from discovery (n = 46), validation (n = 52) and control (n = 68) cohorts. WES of

Updated on: January 08,2024

A predictive biomarker of response to therapy in patients with microsatellite stable metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyA total of 166 patients with mCRCBRAF-V600Ewere included in the study from discovery (n = 46), validation (n = 52) and control (n = 68) cohorts. WES of

Updated on:January 08,2024